Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
724 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
- Where
- Shenzhen
- Életkor
- 18 év and over
- People
- 52
- Run by
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
See details and how to joinNCT06776770 - No phaseCsak meghívásosScreening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer
- Where
- Nantong
- Életkor
- 18 év to 85 év
- People
- 300
- Run by
- Affiliated Hospital of Nantong University
See details and how to joinNCT06776835 - 2. fázisTaking peopleA Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 69
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06774222 - No phaseTaking peopleA Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer
- Where
- Chongqing
- Életkor
- 18 év to 80 év
- People
- 122
- Run by
- Southwest Hospital, China
See details and how to joinNCT06760858 - No phaseNot yet taking people in KínaSafety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 20 év and over
- People
- 10
- Run by
- Energenx Medical LTD.
See details and how to joinNCT06756841 - No phaseTaking peopleDCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
- Where
- Kunming
- Életkor
- 18 év to 80 év
- People
- 135
- Run by
- Yunnan Cancer Hospital
See details and how to joinNCT06755866 - No phaseTaking peopleAtrophic Gastritis Predicts the Risk of Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 2042
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06203327 - 2. fázisTaking peopleNeoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06430658 - No phaseTaking peopleSafety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Shandong University
See details and how to joinNCT06748352 - 2. fázisNot yet taking people in KínaComparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 141
- Run by
- Fudan University
See details and how to joinNCT06748508 - 2. fázisNot yet taking people in KínaA Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 63
- Run by
- Peking University
See details and how to joinNCT06745193 - No phaseNot yet taking people in KínaPreliminary Efficacy Analysis of "C" Single Flap Plasty Reconstruction After Laparoscopic Proximal Gastrectomy
- Where
- Yangzhou
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Daorong Wang
See details and how to joinNCT06741501 - No phaseTaking peopleStudy on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer
- Where
- Kunming
- Életkor
- 18 év to 80 év
- People
- 129
- Run by
- Yunnan Cancer Hospital
See details and how to joinNCT06735105 - 1/2. fázisTaking peopleChemoradiotherapy in Unresectable Esophageal Cancer
- Where
- Anyang, Beijing, Changsha, Nanjing
- Életkor
- 18 év to 75 év
- People
- 105
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT04278287 - No phaseTaking peopleFirst-Line and Neoadjuvant Immunotherapy for Gastric Cancer
- Where
- Jinan
- Életkor
- 18 év to 100 év
- People
- 500
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06727981 - No phaseTaking peopleThe Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 500
- Run by
- Sun Yat-sen University
See details and how to joinNCT06019455 - 2. fázisTaking peopleNimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 112
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06718205 - 2. fázisTaking peopleHS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
- Where
- Anyang, Chengdu, Fujian, Fuzhou, Guangzhou, Harbin, Hefei, Jining, Luoyang, Nanchang, Nantong, Nanyang, Shenyang, Ürümqi, Wuhan, Wuxi, Xinxiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 220
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06112704 - 2. fázisTaking peopleTrifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 31
- Run by
- LIN YANG
See details and how to joinNCT06711471 - 2. fázisTaking peopleA Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)
- Where
- Shanghai
- Életkor
- 20 év to 75 év
- People
- 52
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06709417 - No phaseTaking peopleInfluence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 10
- Run by
- Renmin Hospital of Wuhan University
See details and how to joinNCT05894369 - No phaseTaking peopleThe Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 112
- Run by
- Lin Liu
See details and how to joinNCT06702683 - 2. fázisTaking peopleCamrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 188
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT05738434 - 1. fázisTaking peopleStudy of IBI363 in Patients with Advanced First-line Gastric Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Xiangdong Cheng
See details and how to joinNCT06610799 - 3. fázisTaking peopleA Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 155
- Run by
- Renmin Hospital of Wuhan University
See details and how to joinNCT05919030